Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Avi Porath

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
The Israel Medical Association Journal : IMAJ|September 26, 2003
A prospective national survey of management and clinical outcome of acute myocardial infarction in Israel, 2000Solomon Behar, Alexander Battler, Avi Porath, et al.
Archives of Internal Medicine|November 25, 2010
Metformin use and mortality among patients with diabetes and atherothrombosisRonan Roussel, Florence Travert, Blandine Pasquet, et al.
European Heart Journal|October 20, 2009
Atrial fibrillation and long-term prognosis in patients hospitalized for heart failure: results from heart failure survey in Israel (HFSIS)Avraham Shotan, Moshe Garty, David S Blondhein, et al.
The Israel Medical Association Journal : IMAJ|May 12, 2007
Late mortality and determinants in patients with heart failure and preserved systolic left ventricular function: the Israel Nationwide Heart Failure SurveyBasil S Lewis, Avraham Shotan, Shmuel Gottlieb, et al.
Circulation|April 12, 2012
Global variation in the prevalence of elevated cholesterol in outpatients with established vascular disease or 3 cardiovascular risk factors according to national indices of economic development and health system performanceLakshmi Venkitachalam, Kaijun Wang, Avi Porath, et al.
International Journal of Cardiology|May 8, 2012
Thiazolidinedione use is not associated with worse cardiovascular outcomes: a study in 28,332 high risk patients with diabetes in routine clinical practice: brief title: thiazolidinedione use and mortalityRonan Roussel, Samy Hadjadj, Blandine Pasquet, et al.
The Israel Medical Association Journal : IMAJ|April 7, 2009
Computerized community cholesterol control (4C): meeting the challenge of secondary preventionHarel Gilutz, Lena Novack, Pesach Shvartzman, et al.
European Journal of Preventive Cardiology|August 7, 2013
Metabolic syndrome, diabetes mellitus, or both and cardiovascular risk in outpatients with or at risk for atherothrombosisJacob A Udell, Ph Gabriel Steg, Benjamin M Scirica, et al.
The Lancet. Diabetes & Endocrinology|January 13, 2022
Trends in all-cause mortality among people with diagnosed diabetes in high-income settings: a multicountry analysis of aggregate dataDianna J Magliano, Lei Chen, Bendix Carstensen, et al.
The Lancet. Diabetes & Endocrinology|February 26, 2021
Trends in the incidence of diagnosed diabetes: a multicountry analysis of aggregate data from 22 million diagnoses in high-income and middle-income settingsDianna J Magliano, Lei Chen, Rakibul M Islam, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
The Israel Medical Association Journal : IMAJ|September 26, 2003
A prospective national survey of management and clinical outcome of acute myocardial infarction in Israel, 2000Solomon Behar, Alexander Battler, Avi Porath, et al.
Archives of Internal Medicine|November 25, 2010
Metformin use and mortality among patients with diabetes and atherothrombosisRonan Roussel, Florence Travert, Blandine Pasquet, et al.
European Heart Journal|October 20, 2009
Atrial fibrillation and long-term prognosis in patients hospitalized for heart failure: results from heart failure survey in Israel (HFSIS)Avraham Shotan, Moshe Garty, David S Blondhein, et al.
The Israel Medical Association Journal : IMAJ|May 12, 2007
Late mortality and determinants in patients with heart failure and preserved systolic left ventricular function: the Israel Nationwide Heart Failure SurveyBasil S Lewis, Avraham Shotan, Shmuel Gottlieb, et al.
Circulation|April 12, 2012
Global variation in the prevalence of elevated cholesterol in outpatients with established vascular disease or 3 cardiovascular risk factors according to national indices of economic development and health system performanceLakshmi Venkitachalam, Kaijun Wang, Avi Porath, et al.
International Journal of Cardiology|May 8, 2012
Thiazolidinedione use is not associated with worse cardiovascular outcomes: a study in 28,332 high risk patients with diabetes in routine clinical practice: brief title: thiazolidinedione use and mortalityRonan Roussel, Samy Hadjadj, Blandine Pasquet, et al.
The Israel Medical Association Journal : IMAJ|April 7, 2009
Computerized community cholesterol control (4C): meeting the challenge of secondary preventionHarel Gilutz, Lena Novack, Pesach Shvartzman, et al.
European Journal of Preventive Cardiology|August 7, 2013
Metabolic syndrome, diabetes mellitus, or both and cardiovascular risk in outpatients with or at risk for atherothrombosisJacob A Udell, Ph Gabriel Steg, Benjamin M Scirica, et al.
The Lancet. Diabetes & Endocrinology|January 13, 2022
Trends in all-cause mortality among people with diagnosed diabetes in high-income settings: a multicountry analysis of aggregate dataDianna J Magliano, Lei Chen, Bendix Carstensen, et al.
The Lancet. Diabetes & Endocrinology|February 26, 2021
Trends in the incidence of diagnosed diabetes: a multicountry analysis of aggregate data from 22 million diagnoses in high-income and middle-income settingsDianna J Magliano, Lei Chen, Rakibul M Islam, et al.
Pageof 9